Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVLP with Oxaliplatin for Resectable Pulmonary Metastases of Colorectal Cancer
NCT05611034Phase 1Recruiting
- Sponsor
- University Health Network
- Start
- Feb 2023
- Primary completion
- Aug 2031
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC), sponsored by University Health Network. Primary endpoint: Safety as measured by acute lung injury findings at 72 hours. Started Feb 2023; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05611034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05611034.